Literature DB >> 3843126

HLA and hypertrophic cardiomyopathy.

F B Ren, Y Z Rong, X R Yu, M H Zhao, T M Zhao, W J Gu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3843126     DOI： 10.1007/bf02860941

Source DB:  PubMed          Journal:  Acta Acad Med Wuhan        ISSN： 0253-3316


× No keyword cloud information.
  7 in total

1.  HL-A and hypertrophic cardiomyopathy.

Authors:  A Matsumori; K Hirose; A Wakabayashi; C Kawai; N Nabeya; T Sakurami; K Tsuji
Journal:  Am Heart J       Date:  1979-04       Impact factor: 4.749

2.  The histocompatibility system and human disease.

Authors:  J G Schaller; G S Omenn
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

3.  HLA in hypertrophic cardiomyopathy and rheumatic heart disease.

Authors:  A Matsumori; K Hirose; A Wakabayashi; C Kawai; N Nabeya; T Sakurami; K Tsuji
Journal:  Jpn Circ J       Date:  1979-05

4.  Standardization of the HLA typing method and reagents. Report of a workshop held on November 11, 1976, by the Bureau of Biologics, Food and Drug Administration, United States Department of Health, Education and Welfare.

Authors:  K K Mittal
Journal:  Vox Sang       Date:  1978       Impact factor: 2.144

5.  Hypertrophic cardiomyopathy and human leukocyte antigen linkage: differentiation of two forms of hypertrophic cardiomyopathy.

Authors:  J R Darsee; S B Heymsfield; D O Nutter
Journal:  N Engl J Med       Date:  1979-04-19       Impact factor: 91.245

6.  HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

Authors:  A Matsumori; C Kawai; A Wakabayashi; P I Terasaki; M S Park; T Sakurami; Y Ueno
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

7.  HLA-linked genetic control of host response to Mycobacterium leprae.

Authors:  R R de Vries; R F Fat; L E Nijenhuis; J J van Rood
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.